About the Study

Type 1 Diabetes Stage 2: A study to possibly prevent or delay progression to Stage 3 T1D

This study is for children: • Able to have low dose Antithymocyte Globulin (ATG) • Able to have infusion therapy The goal of this study is to learn if ATG can help prevent or delay progression to clinical diagnosis of type 1 diabetes in people that is having multiple autoantibodies with abnormal glucose status (called stage 2 diabetes) and at least one of the high-risk marker(s) who are at greater risk of progression to clinical diabetes.

Interested in learning more?

Full Study Name: TN-28 STOP-T1D